Viewing Study NCT06665256


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2025-12-27 @ 1:24 AM
Study NCT ID: NCT06665256
Status: RECRUITING
Last Update Posted: 2025-10-28
First Post: 2024-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Study of Rapcabtagene Autoleucel in Myositis
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module